NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/02/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9.82 mln
Float24.18 mln
Earnings Date08/18/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-4.83
Highly reliable
Relative Strength
59
/ 100
Slightly ahead
Debt / Equity
0.00
Debt-free
ROE
-333
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
BioRestorative Therapies Inc. is a medical company based in Melville, New York, that uses adult stem cells to develop treatments for back and spine conditions as well as obesity and related metabolic diseases. Its two main candidates are BRTX-100, a stem cell therapy drawn from a patient's own bone marrow to treat painful spinal disc disorders without surgery, and ThermoStem, which uses a specific type of fat-derived stem cell to address obesity. The company also offers a specialized needle device designed to deliver stem cells and other treatments directly to the spine and other areas of the body. BioRestorative Therapies holds research partnerships with Pfizer, Rohto Pharmaceutical, and the University of Pennsylvania.
